Literature DB >> 15890346

Blocking the cleavage at midportion between gamma- and epsilon-sites remarkably suppresses the generation of amyloid beta-protein.

Toru Sato1, Yu Tanimura, Naoko Hirotani, Takaomi C Saido, Maho Morishima-Kawashima, Yasuo Ihara.   

Abstract

To examine how gamma- and epsilon-cleavages of beta-amyloid precursor protein (APP) are related, each cleavage site was replaced with a stretch of Trp that cannot be cleaved by gamma-secretase. Replacement of the gamma- or epsilon-site significantly suppressed secretion of amyloid beta-protein (Abeta), and produced longer Abeta or longer APP intracellular domain, respectively. This cleavage at the midportion between gamma- and epsilon-sites was also gamma-secretase-dependent. Blocking this cleavage with a Trp stretch remarkably suppressed Abeta generation, indicating that the midportion cleavage is required for the generation of Abeta.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890346     DOI: 10.1016/j.febslet.2005.04.037

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

Review 1.  Structure and mechanism of intramembrane protease.

Authors:  Ya Ha
Journal:  Semin Cell Dev Biol       Date:  2008-11-19       Impact factor: 7.727

Review 2.  Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.

Authors:  Geneviève Evin; Marijke Fleur Sernee; Colin L Masters
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 3.  Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease.

Authors:  Bart De Strooper
Journal:  EMBO Rep       Date:  2007-02       Impact factor: 8.807

Review 4.  When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease.

Authors:  Michael S Wolfe
Journal:  EMBO Rep       Date:  2007-02       Impact factor: 8.807

Review 5.  BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.

Authors:  Neville Marks; Martin J Berg
Journal:  Neurochem Res       Date:  2009-09-17       Impact factor: 3.996

6.  Biology and pathophysiology of the amyloid precursor protein.

Authors:  Hui Zheng; Edward H Koo
Journal:  Mol Neurodegener       Date:  2011-04-28       Impact factor: 14.195

Review 7.  Molecular mechanism of the intramembrane cleavage of the β-carboxyl terminal fragment of amyloid precursor protein by γ-secretase.

Authors:  Maho Morishima-Kawashima
Journal:  Front Physiol       Date:  2014-11-27       Impact factor: 4.566

8.  γ-Secretase-Dependent Proteolysis of Transmembrane Domain of Amyloid Precursor Protein: Successive Tri- and Tetrapeptide Release in Amyloid β-Protein Production.

Authors:  Mako Takami; Satoru Funamoto
Journal:  Int J Alzheimers Dis       Date:  2012-12-31

9.  γ-Secretase Modulators and APH1 Isoforms Modulate γ-Secretase Cleavage but Not Position of ε-Cleavage of the Amyloid Precursor Protein (APP).

Authors:  Christian B Lessard; Barbara A Cottrell; Hiroko Maruyama; Suraj Suresh; Todd E Golde; Edward H Koo
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

10.  Biological function of Presenilin and its role in AD pathogenesis.

Authors:  Shuting Zhang; Mingming Zhang; Fang Cai; Weihong Song
Journal:  Transl Neurodegener       Date:  2013-07-17       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.